Evaluation of human papillomavirus DNA detection in samples obtained for routine Chlamydia trachomatis screening.

Summary, in English

The costs and logistics involved in obtaining samples is a bottleneck in large-scale studies of the circulation of human papillomavirus (HPV), which are useful for monitoring and optimisation of HPV-vaccination programs. Residual samples obtained after screening for Chlamydia trachomatis could constitute a convenient, low-cost solution.

• Author: Anna Söderlund Strand; Arne Wikström; Joakim Dillner
• Department/s: Clinical Microbiology, Malmö
• Publishing year: 2015
• Language: English
• Pages: 88-91
• Publication/Series: Journal of Clinical Virology
• Volume: 64
• Links: http://www.ncbi.nlm.nih.gov/pubmed/25728085?dopt=Abstract; http://dx.doi.org/10.1016/j.jcv.2015.01.008
• Document type: Journal article
• Publisher: Elsevier
• Topic: Infectious Medicine
• Status: Published
• Research group: Clinical Microbiology, Malmö
• ISBN/ISSN/Other: ISSN: 1386-6532